about
Protein Intake and Muscle Health in Old Age: From Biological Plausibility to Clinical EvidenceAnorexia of Aging: Risk Factors, Consequences, and Potential TreatmentsBiomarkers for physical frailty and sarcopenia: state of the science and future developmentsAnorexia of aging: a modifiable risk factor for frailtySarcopenia in heart failure: mechanisms and therapeutic strategiesInappropriate drugs in elderly patients with severe cognitive impairment: results from the shelter studyAssessment of nursing home residents in Europe: the Services and Health for Elderly in Long TERm care (SHELTER) studyImpact of physical function impairment and multimorbidity on mortality among community-living older persons with sarcopaenia: results from the ilSIRENTE prospective cohort studySelf-assessed health status, walking speed and mortality in older Mexican-Americans.Development of CRIteria to assess appropriate Medication use among Elderly complex patients (CRIME) project: rationale and methodology.Exercise and Protein Intake: A Synergistic Approach against SarcopeniaRecommendations to prescribe in complex older adults: results of the CRIteria to assess appropriate Medication use among Elderly complex patients (CRIME) project.Potentially inappropriate drug use among hospitalised older adults: results from the CRIME study.Sarcopenia as the Biological Substrate of Physical Frailty.Biomarkers for physical frailty and sarcopenia.Sarcopenia: an overview.Measurement of muscle mass in sarcopenia: from imaging to biochemical markers.Physical activity and exercise as countermeasures to physical frailty and sarcopenia.Age-Related Variations of Muscle Mass, Strength, and Physical Performance in Community-Dwellers: Results From the Milan EXPO Survey.Biomarkers for sarcopenia: reductionism vs. complexity.Serum levels of C-terminal agrin fragment (CAF) are associated with sarcopenia in older multimorbid community-dwellers: Results from the ilSIRENTE study.Sleep disruption following paramedian pontine stroke.Midarm muscle circumference, physical performance and mortality: results from the aging and longevity study in the Sirente geographic area (ilSIRENTE study).Sarcopenia and mortality among older nursing home residents.Polypharmacy in nursing home residents with severe cognitive impairment: results from the SHELTER Study.Association of anorexia with sarcopenia in a community-dwelling elderly population: results from the ilSIRENTE study.Anorexia, physical function, and incident disability among the frail elderly population: results from the ilSIRENTE study.Intradialytic hypotension is associated with dialytic age in patients on chronic hemodialysis.Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study.Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study.[Just 6 minutes to get to the heart of frailty: the walking test in geriatric cardiology].Cognitive performance is associated with left ventricular function in older chronic hemodialysis patients: result of a pilot study.Animal-Derived Protein Consumption Is Associated with Muscle Mass and Strength in Community-Dwellers: Results from the Milan EXPO Survey.Age-related changes of skeletal muscle mass and strength among Italian and Taiwanese older people: Results from the Milan EXPO 2015 survey and the I-Lan Longitudinal Aging Study.Calf circumference, frailty and physical performance among older adults living in the community.Impact of habitual physical activity and type of exercise on physical performance across ages in community-living people.Effects of anorexia on mortality among older adults receiving home care: an observation study.Polypharmacy in nursing home in Europe: results from the SHELTER study.[Interventions to optimize pharmacologic treatment in hospitalized older adults: a systematic review].Association of pain with behavioral and psychiatric symptoms among nursing home residents with cognitive impairment: results from the SHELTER study.
P50
Q26748961-DC0A0BF2-C734-430D-B6F2-EBA579269A62Q26772927-C7684932-3F55-4F68-ABCF-62702961389DQ26775328-4573B301-6A8B-444E-A972-95043CB2EE41Q27023156-FDCF2D8E-0B3D-47F3-87B8-27F0694DAA9DQ28066237-0B99DFBB-7D09-4D5C-94E9-9E23DDD89E45Q28484216-4A4EED85-4699-4073-AC0F-A196E375AA54Q34122240-030F47D4-E109-4777-8C76-2105C3DF4505Q37134141-527F8CC5-A07D-4779-8C56-6AA64271C342Q37466782-3935B041-E1BE-41F2-B281-BB5ABAF1EE5BQ37688018-BCAF4887-FCDD-4CA6-892F-368651E7A3C0Q37736400-1D701CFB-4940-48BD-9834-4DD6FA717A47Q38162813-0EE381C1-E305-4A6E-B37B-B4E5B64CEF2FQ38196680-84CE0FE8-03AB-4E9B-8B6D-2B1D5FDB0F77Q38551165-1108C392-D72A-4ABA-9FA7-BD55C5D08192Q39117124-F65EABDA-D10A-4692-AE11-6CD658C645E6Q39117131-944B5284-31DA-4FCA-B8BD-0D8266EA1431Q39125530-E84986E7-E4CB-4471-9779-D4F44929E848Q39127874-EE5FC3FD-7498-4646-9377-7DCB53EF88ADQ39133382-CBB137D4-B2EE-4B43-B7DB-4B37A2369854Q39316191-BD4DBA7D-80CD-43A6-BB1C-D6813E0F9C5BQ39888604-8E7DD96E-896A-4C65-B7A2-80A9F16336D6Q41874899-8A94A342-5A8C-4F1D-BED9-3AB7ABB93C44Q43179821-498E5DF7-27BE-4647-9242-7198509E8A31Q43488980-CAF3CD30-DCA2-42C0-A43A-E9A53C593B53Q43522765-E1F387C5-307D-4F69-A418-AD71DC694581Q44043076-5B181286-E203-4293-AB60-B6C2B0587642Q44674078-61B75834-AF5C-44A1-99A6-27A5415FA45EQ45722614-0C2E8203-C17C-4B31-A6E4-C72E68D5D241Q45815700-626F1739-6FF9-4486-B198-BE56088AE926Q46354243-A3A9E144-5298-462F-9EFE-C37E16F12A46Q46427442-6DB845EB-6C92-4EB4-8D7B-BFB5E801BA7AQ46621307-3569D415-AE94-4D07-9ADE-43079A1C593DQ47588594-7339B73D-8876-4C67-8574-9904BBA4DF36Q47677656-A53AD24F-3A4B-46FC-9FC2-15E8B5CCCB62Q47774193-F682CC3D-9848-411F-9BE2-870278D00BCCQ48165213-0F1649E1-CF67-484F-A85E-FD369A7A5394Q48761282-9DAA937D-08DD-4574-9984-0C7317578E02Q48766193-279829A4-38F1-49EC-8913-3BE78CE0F508Q50254333-304C8E54-15FE-4FF5-81D4-BF39460B460DQ50779390-AD4CF2AF-49B1-4D9E-A0E3-8A2A31544C23
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Matteo Tosato
@ast
Matteo Tosato
@en
Matteo Tosato
@es
Matteo Tosato
@nl
Matteo Tosato
@sl
type
label
Matteo Tosato
@ast
Matteo Tosato
@en
Matteo Tosato
@es
Matteo Tosato
@nl
Matteo Tosato
@sl
prefLabel
Matteo Tosato
@ast
Matteo Tosato
@en
Matteo Tosato
@es
Matteo Tosato
@nl
Matteo Tosato
@sl
P106
P1153
23475904200
P21
P31
P496
0000-0001-5750-9746